# IMPACT: A Randomized WOO Study of Novel Therapeutic Agents in Women Triaged to Primary Surgery for EOC

> **NCT03378297** · EARLY_PHASE1 · COMPLETED · sponsor: **Haukeland University Hospital** · enrollment: 26 (actual)

## Conditions studied

- Ovarian Cancer

## Interventions

- **DRUG:** Metformin
- **DRUG:** Acetylsalicylic acid
- **DRUG:** Olaparib
- **DRUG:** Letrozole

## Key facts

- **NCT ID:** NCT03378297
- **Lead sponsor:** Haukeland University Hospital
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-05-04
- **Primary completion:** 2023-01-05
- **Final completion:** 2023-01-05
- **Target enrollment:** 26 (ACTUAL)
- **Last updated:** 2024-10-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03378297

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03378297, "IMPACT: A Randomized WOO Study of Novel Therapeutic Agents in Women Triaged to Primary Surgery for EOC". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT03378297. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*